In-vivo Thrombogenicity Test
The In-vivo Thrombogenicity test determines a comparative thromboresistent for medical devices that are intended for blood contact. This test enables manufacturers to see if the medical devices cause any potentially undesirable effects on humans, such as activation of platelets, formation of a thrombus, embolism or injury to cells. This test complies with ISO 10993-4.
Download the biocompatibility test matrix. [Based on ISO 10993-1:2010 (E) and FDA "Use of international standard ISO 10993-1"]
- ISO 10993
Ask an expert for a specific consultation on your product. If you are ready to submit your samples for testing, click here to fill out the Sample Submission Form.
|SCX670||Hemocompatibility: Dog Thrombogenicity||Add|
|SCX680||Hemocompatibility: Pig Thrombogenicity||Add|
|SCX690||Hemocompatibility: Sheep Thrombogenicity||Add|
SCX670 - Hemocompatibility: Dog Thrombogenicity
SCX680 - Hemocompatibility: Pig Thrombogenicity
SCX690 - Hemocompatibility: Sheep Thrombogenicity
SCX670: 4 test devices and 4 predicates. CSS Approval is needed to meet TAT.
SCX680: 2 test devices and 2 predicates. CSS Approval is needed to meet TAT.
SCX690: 2 test devices and 2 predicates. CSS Approval is needed to meet TAT.